Peter Küster

492 total citations
13 papers, 301 citations indexed

About

Peter Küster is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Surgery. According to data from OpenAlex, Peter Küster has authored 13 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 3 papers in Infectious Diseases and 3 papers in Surgery. Recurrent topics in Peter Küster's work include Cystic Fibrosis Research Advances (8 papers), Bacterial biofilms and quorum sensing (3 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). Peter Küster is often cited by papers focused on Cystic Fibrosis Research Advances (8 papers), Bacterial biofilms and quorum sensing (3 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). Peter Küster collaborates with scholars based in Germany, United States and Italy. Peter Küster's co-authors include Barbara C. Kahl, Angelika Dübbers, Georg Peters, Jean C. Lee, Johannes Birtel, Hirschhausen Nina, Claudia Neumann, Irene Bianconi, Alessandra Bragonzi and Christina Keßler and has published in prestigious journals such as PLoS ONE, Journal of Clinical Microbiology and Frontiers in Immunology.

In The Last Decade

Peter Küster

12 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Küster Germany 10 171 129 118 45 35 13 301
Martina Rossitto Italy 5 189 1.1× 40 0.3× 75 0.6× 40 0.9× 55 1.6× 15 381
Gulnaz Bashir India 11 73 0.4× 151 1.2× 29 0.2× 84 1.9× 65 1.9× 38 337
F. Wallet France 4 152 0.9× 129 1.0× 143 1.2× 88 2.0× 12 0.3× 7 309
Kiyoshi Negayama Japan 11 84 0.5× 75 0.6× 63 0.5× 92 2.0× 48 1.4× 30 343
Joseph Hatch United States 8 181 1.1× 56 0.4× 314 2.7× 91 2.0× 33 0.9× 18 451
Barbara J. Waddell Canada 13 149 0.9× 36 0.3× 178 1.5× 62 1.4× 70 2.0× 28 380
Amanda J. Hall United Kingdom 8 90 0.5× 55 0.4× 19 0.2× 47 1.0× 68 1.9× 8 286
Б.М. Блохин Russia 5 114 0.7× 75 0.6× 70 0.6× 18 0.4× 7 0.2× 21 334
Ize Imai United States 7 123 0.7× 106 0.8× 91 0.8× 111 2.5× 11 0.3× 7 342
Daniela Dolce Italy 10 170 1.0× 53 0.4× 209 1.8× 45 1.0× 56 1.6× 31 365

Countries citing papers authored by Peter Küster

Since Specialization
Citations

This map shows the geographic impact of Peter Küster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Küster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Küster more than expected).

Fields of papers citing papers by Peter Küster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Küster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Küster. The network helps show where Peter Küster may publish in the future.

Co-authorship network of co-authors of Peter Küster

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Küster. A scholar is included among the top collaborators of Peter Küster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Küster. Peter Küster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Küster, Peter, et al.. (2023). Genital herpes zoster in childhood. Deutsches Ärzteblatt international. 120(26). 446–446. 1 indexed citations
2.
Dübbers, Angelika, Jörg Große-Onnebrink, Christina Keßler, et al.. (2019). The prevalence of Staphylococcus aureus with mucoid phenotype in the airways of patients with cystic fibrosis—A prospective study. International Journal of Medical Microbiology. 309(5). 283–287. 14 indexed citations
3.
Herzog, Susann, Nicole de Buhr, Silke Niemann, et al.. (2019). High Nuclease Activity of Long Persisting Staphylococcus aureus Isolates Within the Airways of Cystic Fibrosis Patients Protects Against NET-Mediated Killing. Frontiers in Immunology. 10. 2552–2552. 29 indexed citations
4.
Neumann, Claudia, Stefanie Kampmeier, Susann Herzog, et al.. (2018). Staphylococcus aureus in the airways of cystic fibrosis patients - A retrospective long-term study. International Journal of Medical Microbiology. 308(6). 631–639. 42 indexed citations
5.
Kathemann, Simone, Peter Küster, Verena Keitel, et al.. (2017). Cholestasis After Pediatric Liver Transplantation–Recurrence of a Progressive Familial Intrahepatic Cholestasis Phenotype as a Rare Differential Diagnosis: A Case Report. Transplantation Proceedings. 49(7). 1628–1633. 3 indexed citations
6.
Birtel, Johannes, Alexander Mellmann, Hirschhausen Nina, et al.. (2016). Dynamic in vivo mutations within the ica operon during persistence of Staphylococcus aureus in the airways of cystic fibrosis patients. PLoS Pathogens. 12(11). e1006024–e1006024. 38 indexed citations
7.
Idelevich, Evgeny A., Angelika Dübbers, Peter Küster, et al.. (2015). Increased Prevalence and Resistance of Important Pathogens Recovered from Respiratory Specimens of Cystic Fibrosis Patients During a Decade. The Pediatric Infectious Disease Journal. 34(7). 700–705. 36 indexed citations
8.
Tchesnokova, Veronika, Angelika Dübbers, Peter Küster, et al.. (2014). Prevalence and persistence of Escherichia coli in the airways of cystic fibrosis patients—An unrecognized CF pathogen?. International Journal of Medical Microbiology. 304(3-4). 415–421. 21 indexed citations
9.
Nina, Hirschhausen, Irene Bianconi, Alessandra Bragonzi, et al.. (2013). Extended Staphylococcus aureus persistence in cystic fibrosis is associated with bacterial adaptation. International Journal of Medical Microbiology. 303(8). 685–692. 64 indexed citations
10.
Kahl, Barbara C., et al.. (2009). Emergence of Respiratory Streptococcus agalactiae Isolates in Cystic Fibrosis Patients. PLoS ONE. 4(2). e4650–e4650. 10 indexed citations
11.
Ratjen, Félix, Angelika Dübbers, Johannes Häberle, et al.. (2007). Nasal Staphylococcus aureus Carriage Is Not a Risk Factor for Lower-Airway Infection in Young Cystic Fibrosis Patients. Journal of Clinical Microbiology. 45(9). 2979–2984. 18 indexed citations
12.
Behrens, R., Thomas Lang, Kelly Moura Keller, et al.. (1999). Dual versus triple therapy of Helicobacter pylori infection: results of a multicentre trial. Archives of Disease in Childhood. 81(1). 68–70. 25 indexed citations
13.
Küster, Peter, et al.. (1999). Erfahrungen mit der DNase-Langzeit-Therapie bei Mukoviszidose. Monatsschrift Kinderheilkunde. 147(6). 573–576.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026